PAVmed Inc.
PAVM
$0.649
$0.01913.03%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 3.00M | 4.03M | 3.83M | 3.02M | 2.45M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.00M | 4.03M | 3.83M | 3.02M | 2.45M |
| Cost of Revenue | 4.84M | 6.40M | 6.80M | 6.82M | 6.42M |
| Gross Profit | -1.84M | -2.37M | -2.97M | -3.80M | -3.97M |
| SG&A Expenses | 36.15M | 43.53M | 44.84M | 44.58M | 48.53M |
| Depreciation & Amortization | 559.00K | 1.06M | 1.49M | 1.89M | 2.02M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 47.48M | 59.72M | 63.46M | 65.45M | 71.25M |
| Operating Income | -44.49M | -55.68M | -59.63M | -62.43M | -68.80M |
| Income Before Tax | 28.43M | 9.88M | -72.58M | -75.56M | -79.26M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 28.43 | 9.88 | -72.58 | -75.56 | -79.26 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 11.36M | 14.45M | 14.84M | 14.11M | 15.09M |
| Net Income | 39.79M | 24.32M | -57.75M | -61.46M | -64.18M |
| EBIT | -44.49M | -55.68M | -59.63M | -62.43M | -68.80M |
| EBITDA | -43.29M | -53.83M | -57.28M | -59.64M | -65.86M |
| EPS Basic | 2.74 | 0.63 | -8.17 | -9.08 | -9.24 |
| Normalized Basic EPS | -1.47 | -2.74 | -3.19 | -3.74 | -4.54 |
| EPS Diluted | -2.38 | -4.35 | -8.18 | -9.08 | -9.24 |
| Normalized Diluted EPS | -1.18 | -2.50 | -3.19 | -3.74 | -4.54 |
| Average Basic Shares Outstanding | 38.68M | 35.88M | 33.33M | 31.14M | 28.92M |
| Average Diluted Shares Outstanding | 194.28M | 70.35M | 33.33M | 31.14M | 28.92M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |